• The global biotechnology market is expected to grow from USD 1.68 trillion in 2024 to USD 3.54 trillion by 2033, representing a CAGR of 9.18%, according to Cervicorn Consulting.
• Red biotechnology, focused on medical applications, is projected to reach USD 649.31 billion by 2033, with monoclonal antibodies dominating the product segment.
• North America leads the global biotechnology market with the highest market share, while Asia Pacific is experiencing the fastest growth due to increasing investments and government support.